SV Health Investors’s Lombard Medical, Inc. EVAR Stock Holding History

SV Health Investors’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,275,779	Closed	-$574K	–	9
2017 Q3	$574K	Hold	1,275,779	–	–	0.44%	7
2017 Q2	$701K	Hold	1,275,779	–	–	0.75%	6
2017 Q1	$995K	Hold	1,275,779	–	–	1.1%	6
2016 Q4	$765K	Hold	1,275,779	–	–	0.64%	6
2016 Q3	$1.2M	Buy	1,275,779 +198,280	+18%	+$210K	0.92%	6
2016 Q2	$1.17M	Hold	1,077,499	–	–	1.19%	6
2016 Q1	$1.13M	Hold	1,077,499	–	–	0.85%	6
2015 Q4	$1.46M	Hold	1,077,499	–	–	1.17%	6
2015 Q3	$3.85M	Buy	+1,077,499	New	+$4.13M	2.15%	6

Other funds holding EVAR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

SV Health Investors's EVAR Position: Q4 2017 in Review

SV Health Investors sold out of Lombard Medical, Inc. (EVAR) in Q4 2017, closing a stake of 1,275,779 shares — an estimated $574K sold.

SV Health Investors first reported a position in EVAR in Q3 2015 and held it in 9 quarters. The position peaked at $3.85M in Q3 2015. 2 funds tracked by Wall St. Rank hold EVAR as of Q4 2017.

SV Health Investors reported no remaining Lombard Medical, Inc. position as of Q4 2017 after selling out during the quarter.
SV Health Investors sold 1,275,779 Lombard Medical, Inc. shares in Q4 2017, an estimated $574K.
SV Health Investors first reported a position in Lombard Medical, Inc. in Q3 2015 and held it in 9 quarters.
SV Health Investors's Lombard Medical, Inc. position peaked at $3.85M in Q3 2015.
2 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2017.

Based on SV Health Investors's 13F filing for Q4 2017, filed 14 Feb 2018.